July 20, 2024
Discover innovative therapeutic strategies targeting quiescent cancer cells to combat tumor resistance and prevent relapse. Learn how to overcome treatment challenges.
February 7, 2024
The development of Enhertu represents a significant advancement in targeted cancer therapy, offering new hope for patients with limited treatment options. Enhertu, also known as trastuzumab deruxtecan, is an innovative antibody-drug conjugate (ADC) designed to target HER2-positive cancers, which are associated with aggressive growth and poor prognosis in various cancer types, including breast and gastric cancers
January 22, 2024
"for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy."
January 19, 2024
Atezolizumab, a programmed death-ligand 1 (PD-L1) inhibitor, has shown promising results in clinical trials when combined with chemotherapy for the treatment of extensive-stage small cell lung cancer (ES-SCLC). However, a real-world evaluation of atezolizumab plus platinum-etoposide chemotherapy in patients with ES-SCLC in Canada raises important considerations regarding its use.
December 16, 2023
During her rotation in obstetrics and gynecology, a resident encountered a 28-year-old pregnant woman at 13 weeks gestational age, who already has three healthy children. I […]
May 17, 2021
What is Doxorubicin Transarterial Chemoembolization (TACE)?
Known as doxorubicin chemoembolization.
March 23, 2021
What is Durvalumab, and how it works? Well, it’s basically an immunoglobulin monoclonal antibody, it works by a very cool trick; where it affects on the […]
January 15, 2021
This is an important thing that's our patients are worried about this. And this is something that we, as a group need to ask ourselves, how can we improve our adherence? and how to deal with ovarian cancer: options and risks
January 15, 2021
Cancer care is advancing. And we have more and more clinical trials, as well as new agents that we need to always remain focused on what our treatments mean, in terms of quality of life for patients and for their families. Because for all of us, quality of life, remains the ultimate goal of all of our cancer treatments.
# Cancer Patient Quality Of Life
